Document is current

Any future updates will be listed below

Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis

Crossref DOI link: https://doi.org/10.1186/s13058-024-01929-z

Published Online: 2024-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark